1-Methylpiperazine → HCID 44578630、化合物
反応式
Cl[C:2]1[CH:3]=[C:4]([CH:28]=[CH:29][N:30]=1)[C:5]([NH:7][C:8]1[CH:9]=[C:10]([C:15]2[CH:20]=[CH:19][C:18]([C:21]([NH:23][CH2:24][CH:25]3[CH2:27][CH2:26]3)=[O:22])=[CH:17][CH:16]=2)[C:11]([CH3:14])=[CH:12][CH:13]=1)=[O:6].[CH3:31][N:32]1[CH2:37][CH2:36][NH:35][CH2:34][CH2:33]1>>[CH:25]1([CH2:24][NH:23][C:21]([C:18]2[CH:19]=[CH:20][C:15]([C:10]3[C:11]([CH3:14])=[CH:12][CH:13]=[C:8]([NH:7][C:5](=[O:6])[C:4]4[CH:28]=[CH:29][N:30]=[C:2]([N:35]5[CH2:36][CH2:37][N:32]([CH3:31])[CH2:33][CH2:34]5)[CH:3]=4)[CH:9]=3)=[CH:16][CH:17]=2)=[O:22])[CH2:27][CH2:26]1参加物
3
実験手順
N-(4′-{[(Cyclopropylmethyl)amino]carbonyl}-6-methyl-1,1′-biphenyl-3-yl)-2-(4-methylpiperazin-1-yl)isonicotinamide was prepared from 2-chloro-N-(4′-{[(cyclopropylmethyl)amino]carbonyl}-6-methyl-1,1′-biphenyl-3yl)isonicotinamide and N-methylpiperazine using method A. NMR; δH [2H6]—DMSO 10.31,(1H, s), 8.62,(1H, t), 8.24,(1H, d), 7.93,(2H, d), 7.71,(1H, dd), 7.64,(1H, d), 7.44,(2H, d), 7.30,(1H, d), 7.23,(1H, s), 7.06,(1H, d), 3.55,(4H, m), 3.16,(2H, t), 2.40,(4H, t), 2.21,(6H, m), 1.04,(1H, m), 0.43,(2H, m), 0.24,(2H, m). LCMS: retention time 2.74 min, MH+484.
出典と根拠
- ORDレコード
- ord-cdf1da84fa3f4169a4d4c405d16a3671
- 出典データセット
- uspto-grants-2008_10
- 特許番号
- US07432289B2
反応ノート
読み込み中…